Table 5.

BMD evaluation during PRME administration period

Regions	SC (g/cm2)	OVX (g/cm2)	OVX + PRME (g/cm2)	OVX + Std (g/cm2)
Head	0.302 ± 0.013	0.290 ± 0.010	0.299 ± 0.002	0.297 ± 0.009
Arms	0.147 ± 0.023	0.114 ± 0.029	0.128 ± 0.017	0.143 ± 0.009
Legs	0.154 ± 0.004	0.134 ± 0.003	0.147 ± 0.008	0.143 ± 0.011
Trunk	0.160 ± 0.006	0.132 ± 0.007	0.141 ± 0.012	0.153 ± 0.008
Ribs	0.151 ± 0.008	0.116 ± 0.007	0.124 ± 0.017	0.138 ± 0.017
Spine	0.165 ± 0.008	0.140 ± 0.006	0.144 ± 0.020	0.160 ± 0.005
Pelvis	0.161 ± 0.005	0.134 ± 0.011	0.150 ± 0.012	0.154 ± 0.012
Total	0.183 ± 0.006	0.164 ± 0.004	0.170 ± 0.006	0.174 ± 0.006

Where: OVX ovariectomized rat, SC Sham control, OVX + PRME ovariectomized rat + Pterospermum rubiginosum methanolic extract, OVX + std ovariectomized rat + alendronic acid, bone mineral density—BMD; Grams per Square Centimetre—g/cm²